baclofen and Congenital Icthyosis Mental Retardation Spasticity Syndrome studies

baclofen and Congenital Icthyosis Mental Retardation Spasticity Syndrome

Research Excerpts

Excerpt	Relevance	Reference
"The current treatment of spasticity in patients with Sjögren-Larsson syndrome is largely symptomatic, given that no effective causal therapy treatments are available."	5.46	Intrathecal Baclofen Therapy for the Treatment of Spasticity in Sjögren-Larsson Syndrome. ( Harter, DH; Hersh, A; Hidalgo, ET; Orillac, C; Rizzo, WB; Weiner, HL, 2017)
"The current treatment of spasticity in patients with Sjögren-Larsson syndrome is largely symptomatic, given that no effective causal therapy treatments are available."	1.46	Intrathecal Baclofen Therapy for the Treatment of Spasticity in Sjögren-Larsson Syndrome. ( Harter, DH; Hersh, A; Hidalgo, ET; Orillac, C; Rizzo, WB; Weiner, HL, 2017)

Research

Studies (1)

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

1 (100.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Studies

Hidalgo, ET

Orillac, C

Hersh, A

Harter, DH

Rizzo, WB

Weiner, HL

Other Studies

1 other study available for baclofen and Congenital Icthyosis Mental Retardation Spasticity Syndrome

Article	Year
Intrathecal Baclofen Therapy for the Treatment of Spasticity in Sjögren-Larsson Syndrome. Journal of child neurology, 2017, Volume: 32, Issue:1 Topics: Baclofen; Child, Preschool; Female; Humans; Infusion Pumps, Implantable; Injections, Spinal; Male; M	2017

Article

Year

Journal of child neurology, 2017, Volume: 32, Issue:1

Topics: Baclofen; Child, Preschool; Female; Humans; Infusion Pumps, Implantable; Injections, Spinal; Male; M

2017